[ASND] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
07-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 46.45%
YoY- 58.11%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 137,702 22,896 4,897 535 2,507 10,515 280 180.81%
PBT -81,088 -202,069 -106,176 -138,982 -80,400 -32,066 -34,361 15.37%
Tax 5,790 5,349 -114 -17 -38 -88 -186 -
NP -86,878 -207,418 -106,062 -138,965 -80,362 -31,978 -34,175 16.81%
Tax Rate - - - - - - - -
Total Cost 224,580 230,314 110,959 139,500 82,869 42,493 34,455 36.65%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -63.09 -905.91 -2,165.86 -25,974.77 -3,205.50 -304.12 -12,205.36 -58.40%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.53 -3.70 -1.97 -2.60 -1.68 -0.76 -0.92 8.84%
EPS Diluted -1.53 -3.70 -1.97 -2.58 -1.67 -0.74 -0.88 9.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.